Retinoic Acid-Regulated Target Genes During Development: Integrative Genomics Analysis.
Fiche publication
Date publication
janvier 2020
Journal
Sub-cellular biochemistry
Auteurs
Membres identifiés du Cancéropôle Est :
Dr ROCHETTE-EGLY Cécile
Tous les auteurs :
Rochette-Egly C
Lien Pubmed
Résumé
Retinoic acid (RA), a major natural active metabolite of vitamin A (VA) is well known to play critical roles in embryonic development. The effects of RA are mediated by nuclear receptors (RARs), which regulate the expression of gene batteries involved in cell growth and differentiation. Since the early 1990s several laboratories have focused on understanding how RA-regulated genes and RAR binding sites operate by studying the differentiation of embryonal carcinoma cells and embryonic stem cells. The development of hybridization-based microarray technology and high performance software analysis programs has allowed the characterization of thousands of RA-regulated genes. During the two last decades, publication of the genome sequence of various organisms has allowed advances in massive parallel sequencing and bioinformatics analysis of genome-wide data sets. These new generation sequencing (NGS) technologies have revolutionized the field by providing a global integrated picture of RA-regulated gene networks and the regulatory programs involved in cell fate decisions during embryonal carcinoma and embryonic stem cells differentiation. Now the challenge is to reconstruct the RA-regulated gene networks at the single cell level during the development of specialized embryonic tissues.
Mots clés
Development, Differentiation, Embryonal carcinoma cells, Embryonic, Embryonic stem cells, Gene networks, NGS, New generation sequencing, Retinoic acid, Retinoic acid-regulated, Retinoids, Transcriptome, Vitamin A
Référence
Subcell. Biochem.. 2020 ;95:57-85